½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting


»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹MTARC1¶à¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • Íÿ¹MTARC1¶à¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW19886
    • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul/200ul/25ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·


ÖÐÎÄÃû³Æ£º Íÿ¹MTARC1¶à¿Ë¡¿¹Ìå


Ó¢ÎÄÃû³Æ£º Anti-MTARC1 rabbit polyclonal antibody


±ð       Ãû£º mitochondrial amidoxime reducing component 1; MARC


Ïà¹ØÀà±ð£º Ò»¿¹


´¢       ´æ£º Àä¶³£¨-20¡æ£©


ËÞ      Ö÷£º Rabbit


¿¹      Ô­£º MTARC1


·´Ó¦ÖÖÊô£º Human


±ê  ¼Ç Î Unconjugate


¿Ë¡ÀàÐÍ£º rabbit polyclonal


¼¼Êõ¹æ¸ñ

Background:

As a component of an N-hydroxylated prodrug-converting complex required to reduce N-hydroxylated prodrugs, such as benzamidoxime. Also able to reduce N(omega)-hydroxy-L-arginine (NOHA) and N(omega)-hydroxy-N(delta)-methyl-L-arginine (NHAM) into L-arginine and N(delta)-methyl-L-arginine, respectively.

Applications:

ELISA, WB, IHC

Name of antibody:

MTARC1

Immunogen:

Synthetic peptide of human MTARC1

Full name:

mitochondrial amidoxime reducing component 1

Synonyms:

MARC1; MOSC1

SwissProt:

Q5VT66

IHC positive control:

Human gasrtic cancer and Human thyroid cancer

IHC Recommend dilution:

50-200

WB Predicted band size:

37 kDa

WB Positive control:

Human normal liver tissue

WB Recommended dilution:

200-1000







¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿